(Q37444118)

English

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

scientific article published on 23 July 2009

Statements

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction (English)
Jay H Traverse
Timothy D Henry
Douglas E Vaughan
Carl J Pepine
James T Willerson
David X M Zhao
Linda B Piller
Marc S Penn
Barry J Byrne
Emerson C Perin
Adrian P Gee
Antonis K Hatzopoulos
David H McKenna
John R Forder
Doris A Taylor
Christopher R Cogle
Rachel E Olson
Beth C Jorgenson
Shelly L Sayre
Rachel W Vojvodic
David J Gordon
Sonia I Skarlatos
Lemuel A Moye'
Robert D Simari
Cardiovascular Cell Therapy Research Network (CCTRN)
23 July 2009
158
356-363

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit